European Investor
14 Oct 2025, 15:40
Scholar Rock Notes FDA Action on Novo Nordisk’s Catalent Facility
Scholar Rock Holding Corp. (NASDAQ: SRRK) announced that Novo Nordisk notified the company the U.S. FDA has classified its Catalent Indiana facility inspection as “Official Action Indicated” (OAI) following a Form 483 issued in July 2025, signaling potential regulatory follow-up or enforcement actions at the site.
Scholar Rock Holding Corp. (NASDAQ: SRRK) announced that Novo Nordisk notified the company the U.S. FDA has classified its Catalent Indiana facility inspection as “Official Action Indicated” (OAI) following a Form 483 issued in July 2025, signaling potential regulatory follow-up or enforcement actions at the site.